Blood component therapy in bone marrow transplantation
Brand, A.; Claas, F.H.; Falkenburg, J.H.; van Rood, J.J.; Eernisse, J.G.
Seminars in Hematology 21(2): 141-155
1984
ISSN/ISBN: 0037-1963 PMID: 6330905 Document Number: 234166
Document emailed within 1 workday
Related Documents
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475Bolwell, B.J.; Fishleder, A.; Andresen, S.W.; Lichtin, A.E.; Koo, A.; Yanssens, T.; Burwell, R.; Baucco, P.; Green, R. 1993: G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment Bone Marrow Transplantation 12(6): 609-614
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Cooley, M.A. 1987: Cytokine activity after human bone marrow transplantation. Production of interferons by peripheral blood mononuclear cells from recipients of HLA-identical sibling bone marrow transplants Journal of Immunology 138(11): 3742-3745
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Ljungman, P.; Cordonnier, C.; de Bock, R.; Einsele, H.; Engelhard, D.; Grundy, J.; Link, H.; Locasciulli, A.; Prentice, G.; Reusser, P. 1995: Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 15(3): 455-460
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Gassmann, W.; von Kolszynski, M.; Wottge, H.U.; Müller-Ruchholtz, W. 1987: Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation Transplantation Proceedings 19(1 Part 3): 2687-2688
León-Rodríguez, E.; Sosa Sánchez, R.; Gómez, E.; Ochoa Sosa, C. 1993: Bone marrow transplantation in aplastic anemia. Experience at a Mexican institution. Bone marrow transplantation group of the Salvador Zubirán National Institute of Nutrition Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 45(6): 559-564
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
Skoff, H.D. 1995: Bone marrow/allograft component therapy. a clinical trial American Journal of Orthopedics 24(1): 40-47
Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837
Chan, K.W.; Herd, S.L.; Stanley, C.E.; Wadsworth, L.D. 1991: ABO-incompatible pediatric bone marrow transplantation: a simple method to remove red blood cells from small volume marrow grafts Bone Marrow Transplantation 8(6): 473-476
Nakayama, H.; Okamura, J.; Ikuno, Y.; Shigeno, K.; Tasaka, H. 1992: Isolated renal relapse after bone marrow transplantation in childhood leukemia. Bone Marrow Transplantation Team Bone Marrow Transplantation 10(2): 195
Duhamel, G.; Gorin, N.C.; Douay, L.; Najman, A.; Stachowiak, J. 1982: Bone marrow repopulation after heavy chemotherapy and autologous bone marrow transplantation. Monitoring with biopsies and marrow culture on agar La Nouvelle Presse Medicale 11(11): 833-836
Bengtsson, M.; Tötterman, T.H.; Smedmyr, B.; Festin, R.; Oberg, G.; Simonsson, B. 1989: Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis Leukemia 3(1): 68-75
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178
Jungerman, M.; Sedzimirska, M.; Lange, A.; Witt, M. 1998: Application of microsatellite markers for monitoring of reconstitution pattern in patients after bone marrow transplantation/peripheral blood progenitor cell transplantation Archivum Immunologiae et Therapiae Experimentalis 46(1): 39-43
De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39